| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/01/2022 | Elicio Therapeutics, Inc. | ANGN | Payment of Exercise | Common Stock | 32.1k | $1.12 | $35.9k | | 07/01/2022 |
| 12/06/2021 | Elicio Therapeutics, Inc. | ANGN | Sale | Common Stock | 32.1k | $3.35 | $107.7k | | 12/06/2021 |
| 12/03/2021 | Elicio Therapeutics, Inc. | ANGN | Sale | Common Stock | 40.2k | $3.39 | $136.2k | | 12/01/2021 |
| 12/02/2021 | Elicio Therapeutics, Inc. | ANGN | Sale | Common Stock | 38.8k | $3.51 | $136.3k | | 12/01/2021 |
| 12/01/2021 | Elicio Therapeutics, Inc. | ANGN | Sale | Common Stock | 38.9k | $3.54 | $137.7k | | 12/01/2021 |
| 11/16/2021 | Elicio Therapeutics, Inc. | ANGN | Sale | Common Stock | 38.5k | $4.26 | $163.8k | | 06/24/2021 |
| 11/15/2021 | Elicio Therapeutics, Inc. | ANGN | Sale | Common Stock | 111.5k | $4.17 | $465.2k | | 06/24/2021 |
| 06/24/2021 | Elicio Therapeutics, Inc. | ANGN | Payment of Exercise | Common Stock | 47.4k | $13.78 | $653.3k | | 06/24/2021 |
| 02/09/2021 | Elicio Therapeutics, Inc. | ANGN | Payment of Exercise | Common Stock | 38.4k | $16.00 | $613.6k | | 02/09/2021 |
| 02/04/2021 | Elicio Therapeutics, Inc. | ANGN | Grant | Stock Option (Right to Buy) | 70k | $16.00 | $1.1M | | 02/04/2021 |